Orthofix International (OFIX) Tops Q2 EPS by 21c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Orthofix Reports Second Quarter 2021 Results
August 6, 2021 7:00 AM EDTNet sales of $121 million, up 66% compared to prior year and 5% compared to the second quarter of 2019 U.S. Spinal Implants net sales grew 56% compared to prior year and 37% over the second quarter of 2019 Strong performance from our U.S. M6-C artificial cervical disc and FITBONE® limb lengthening system with approximately $9 million in combined sales Company raises full year 2021 revenue and adjusted EBITDA guidance
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today reported its financial... More
